Perceptive Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-4,313,611
| Closed | -$41M | – | 125 |
|
|
2018
Q4 | $41M | Hold |
4,313,611
| – | – | 1.56% | 20 |
|
|
2018
Q3 | $86.8M | Hold |
4,313,611
| – | – | 2.32% | 8 |
|
|
2018
Q2 | $126M | Hold |
4,313,611
| – | – | 3.3% | 7 |
|
|
2018
Q1 | $128M | Buy |
4,313,611
+925,000
| +27% | +$27.5M | 3.6% | 6 |
|
|
2017
Q4 | $109M | Buy |
3,388,611
+1,231,600
| +57% | +$39.6M | 3.61% | 6 |
|
|
2017
Q3 | $75M | Hold |
2,157,011
| – | – | 2.87% | 7 |
|
|
2017
Q2 | $64.2M | Buy |
2,157,011
+17,737
| +0.8% | +$528K | 3.23% | 6 |
|
|
2017
Q1 | $63.9M | Buy |
2,139,274
+820,000
| +62% | +$24.5M | 3.64% | 5 |
|
|
2016
Q4 | $23.1M | Sell |
1,319,274
-4,050
| -0.3% | -$71K | 1.64% | 16 |
|
|
2016
Q3 | $31.5M | Sell |
1,323,324
-9,491
| -0.7% | -$226K | 2.03% | 10 |
|
|
2016
Q2 | $21.3M | Buy |
1,332,815
+633,300
| +91% | +$10.1M | 1.48% | 14 |
|
|
2016
Q1 | $14.6M | Buy |
699,515
+50,000
| +8% | +$1.05M | 1.28% | 18 |
|
|
2015
Q4 | $17.5M | Sell |
649,515
-5,000
| -0.8% | -$135K | 1.3% | 19 |
|
|
2015
Q3 | $18.2M | Buy |
654,515
+401,600
| +159% | +$11.2M | 1.45% | 13 |
|
|
2015
Q2 | $6.2M | Hold |
252,915
| – | – | 0.37% | 53 |
|
|
2015
Q1 | $4.63M | Sell |
252,915
-36,040
| -12% | -$659K | 0.36% | 52 |
|
|
2014
Q4 | $5.33M | Buy |
288,955
+38,955
| +16% | +$719K | 0.45% | 48 |
|
|
2014
Q3 | $2.4M | Buy |
+250,000
| New | +$2.4M | 0.24% | 59 |
|